The U.S. Department of Health and Human Services has published a new rule for electronic funds transfers in healthcare.
Updates about recent clinical trials, including the evaluation of Pennvax-B for HIV, tofacitinib for rheumatoid arthritis a universal flu vaccine and more.
Global production of seasonal flu vaccine is expected to double to 1.7 billion doses by 2015, with 11 new manufacturers expected in developing countries.
Responding to concerns about the initial Accountable Care Organization rules, the U.S. Department of Health and Human Services has made several concessions.
The HealthWell Foundation, a nonprofit organization providing financial assistance to insured patients facing a variety of chronic and life-altering illnesses, has launched a new fund to support treatment of systemic lupus erythematosus.
In September, the Justice Department said it would forgo an appeal to the full U.S. 11th Circuit Court of Appeals in Atlanta, which ruled 2-1 in August that the healthcare reform law’s requirement that people buy health insurance is unconstitutional.
Patients with chronic obstructive pulmonary disease are at greater risk of shingles compared with the general population.
Researchers at the Feinberg School ofMedicine have figured out how the immune cells of rheumatoid arthritis patients become hyperactive and attack their joints and bones.
Average annual insurance premiums for employer-sponsored family health coverage increased to $15,073 in 2011, up 9 percent from 2010.
In April, the Centers for Disease Control and Prevention will launch the final deployment of a system to transform the way the agency distributes vaccines to more than 100,000 U.S.doctors and clinicians.
Michigan State University researchers have created a new malaria vaccine that appears to increase the immune response against the parasite that causes the deadly disease.
The U.S. Food and Drug Administration has approved Gilenya, the first oral treatment for multiple sclerosis.